Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024)
Benitec Biopharma (BNTC) reported Asset Utilization Ratio of 0.0 for Q1 2024, down 94.3% on a YoY basis from 0.01 in Q2 2023, and down 84.72% sequentially from 0.0 in Q4 2023.
Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024) Analysis & Trends
Benitec Biopharma (BNTC) has 5 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2024.
- For the quarter ending Q1 2024, Asset Utilization Ratio fell 94.3% year-over-year to 0.0; the trailing twelve-month figure through Mar 2024 stood at 0.0 (down 94.3% YoY), and the FY2023 full-year result was 0.01, up 169.25% from the prior year.
- Asset Utilization Ratio retreated to 0.0 in Q1 2024, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q3 2020 to a low of 0.0 in Q3 2021.
- A 5-year average of 0.0 and a median of 0.0 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio sank 98.33% in 2021 and soared 2871.08% in 2022, its largest moves.
- Tracing BNTC's Asset Utilization Ratio over 5 years: stood at 0.0 in 2020, then sank by 56.17% to 0.0 in 2021, then soared by 134.93% to 0.0 in 2022, then plunged by 38.98% to 0.0 in 2023, then plunged by 84.72% to 0.0 in 2024.
- Business Quant data shows BNTC's Asset Utilization Ratio at 0.0 in Q1 2024, 0.0 in Q4 2023, and 0.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 0.01 |